Cargando…

Dopamine Agonists Exert Nurr1-inducing Effect in Peripheral Blood Mononuclear Cells of Patients with Parkinson's Disease

BACKGROUND: Nurr1 plays an essential role in the development, survival, and function maintenance of midbrain dopaminergic (DA) neurons, and it is a potential target for Parkinson's disease (PD). Nurr1 mRNA can be detected in peripheral blood mononuclear cells (PBMCs), but whether there is any a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Li-Min, Sun, Cong-Cong, Mo, Ming-Shu, Cen, Luan, Wei, Lei, Luo, Fei-Fei, Li, Yi, Li, Guo-Fei, Zhang, Si-Yun, Yi, Li, Huang, Wei, Liu, Zhuo-Lin, Le, Wei-Dong, Xu, Ping-Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4733729/ https://www.ncbi.nlm.nih.gov/pubmed/26112716 http://dx.doi.org/10.4103/0366-6999.159349

Ejemplares similares

Alterations of NURR1 and Cytokines in the Peripheral Blood Mononuclear Cells: Combined Biomarkers for Parkinson’s Disease
por: Li, Tianbai, et al.
Publicado: (2018)

Association Analysis of Proteasome Subunits and Transporter Associated with Antigen Processing on Chinese Patients with Parkinson's Disease
por: Mo, Ming-Shu, et al.
Publicado: (2016)

An optimized Nurr1 agonist provides disease-modifying effects in Parkinson’s disease models
por: Kim, Woori, et al.
Publicado: (2023)

The role of NURR1 in metabolic abnormalities of Parkinson’s disease
por: Al-Nusaif, Murad, et al.
Publicado: (2022)

Efficacy and safety of non‐ergot dopamine‐receptor agonists as an adjunct to levodopa in advanced Parkinson's disease: A network meta‐analysis
por: Chen, Xiang‐Ting, et al.
Publicado: (2022)

Advances in NURR1-Regulated Neuroinflammation Associated with Parkinson’s Disease
por: Al-Nusaif, Murad, et al.
Publicado: (2022)

Comparative efficacy and safety of six non-ergot dopamine-receptor agonists in early Parkinson's disease: a systematic review and network meta-analysis
por: Chen, Xiang-Ting, et al.
Publicado: (2023)

Combined Nurr1 and Foxa2 roles in the therapy of Parkinson's disease
por: Oh, Sang-Min, et al.
Publicado: (2015)

Combined Nurr1 and Foxa2 roles in the therapy of Parkinson's disease
por: Oh, Sang‐Min, et al.
Publicado: (2016)

Enhancing Beta-Catenin Activity via GSK3beta Inhibition Protects PC12 Cells against Rotenone Toxicity through Nurr1 Induction
por: Zhang, Limin, et al.
Publicado: (2016)

Circular RNAs in peripheral blood mononuclear cells from ankylosing spondylitis
por: Tang, Yi-Ping, et al.
Publicado: (2021)

Nemo-like kinase as a negative regulator of nuclear receptor Nurr1 gene transcription in prostate cancer
por: Wang, Jian, et al.
Publicado: (2016)

Selective brain penetrable Nurr1 transactivator for treating Parkinson's disease
por: Wang, Jun, et al.
Publicado: (2016)

Development of a Potent Nurr1 Agonist Tool for In Vivo Applications
por: Vietor, Jan, et al.
Publicado: (2023)

The treatment of Parkinson's disease with dopamine agonists
por: Konta, Brigitte, et al.
Publicado: (2008)

Multi‐omics integrative analysis identified SNP‐methylation‐mRNA: Interaction in peripheral blood mononuclear cells
por: Lu, Yi‐Hua, et al.
Publicado: (2019)

Dopamine agonist responsive burning mouth syndrome: Report of eight cases
por: Du, Qi-Cui, et al.
Publicado: (2021)

Expression Profile and Potential Function of Circular RNAs in Peripheral Blood Mononuclear Cells in Male Patients With Primary Gout
por: Dai, Fei, et al.
Publicado: (2021)

Region Specific Effects of Aging and the Nurr1-Null Heterozygous Genotype on Dopamine Neurotransmission
por: Kummari, Evangel, et al.
Publicado: (2017)

Minocycline Protects against Rotenone-Induced Neurotoxicity Correlating with Upregulation of Nurr1 in a Parkinson's Disease Rat Model
por: Sun, Congcong, et al.
Publicado: (2019)

Dopamine Agonist Therapy in Advanced Parkinson’s Disease
por: Reichmann, Heinz
Publicado: (2009)

Upregulation of APAF1 and CSF1R in Peripheral Blood Mononuclear Cells of Parkinson’s Disease
por: Chang, Kuo-Hsuan, et al.
Publicado: (2023)

Apoptosis gene reprograming of human peripheral blood mononuclear cells induced by radioiodine-131 ((131)I) irradiation
por: Li, Jian-Fang, et al.
Publicado: (2019)

Structure-Guided Design of Nurr1 Agonists Derived from the Natural Ligand Dihydroxyindole
por: Sai, Minh, et al.
Publicado: (2023)

Dopamine enhances willingness to exert effort for reward in Parkinson's disease
por: Chong, Trevor T.-J., et al.
Publicado: (2015)

7.0T ultrahigh-field MRI directly visualized the pedunculopontine nucleus in Parkinson's disease patients
por: Wang, Jia-Wei, et al.
Publicado: (2019)

Integrative analysis reveals structural basis for transcription activation of Nurr1 and Nurr1-RXRα heterodimer
por: Zhao, Mohan, et al.
Publicado: (2022)

Tau Pathology in Parkinson's Disease
por: Zhang, Xue, et al.
Publicado: (2018)

Dopamine agonist monotherapy utilization in patients with Parkinson’s disease
por: Frazer, Monica, et al.
Publicado: (2022)

Revisiting the Medical Management of Parkinson's Disease: Levodopa versus Dopamine Agonist
por: Zhang, Jinglin, et al.
Publicado: (2016)

Midbrain dopamine neurons arbiter OCD-like behavior
por: Xue, Jinwen, et al.
Publicado: (2022)

Long 3'UTR of Nurr1 mRNAs is targeted by miRNAs in mesencephalic dopamine neurons
por: Pereira, Luis Alberto, et al.
Publicado: (2017)

Lower PRDM2 expression is associated with dopamine-agonist resistance and tumor recurrence in prolactinomas
por: Gao, Hua, et al.
Publicado: (2015)

Transplantation of Nurr1‐overexpressing neural stem cells and microglia for treating parkinsonian rats
por: Qian, Yuan, et al.
Publicado: (2019)

Pituitary adenylate cyclase-activating polypeptide expression in peripheral blood mononuclear cells of migraineurs
por: Hou, Lei, et al.
Publicado: (2016)

Causes and factors related to dopamine agonist withdrawal in Parkinson′s disease
por: Castro, Ester Suárez, et al.
Publicado: (2016)

Severe disturbance of glucose metabolism in peripheral blood mononuclear cells of schizophrenia patients: a targeted metabolomic study
por: Liu, Mei-Ling, et al.
Publicado: (2015)

The Transcription Factor NURR1 Exerts Concentration-Dependent Effects on Target Genes Mediating Distinct Biological Processes
por: Johnson, Magen M., et al.
Publicado: (2011)

Dopamine alters phage morphology to exert an anti-infection effect
por: Zhang, Shengting, et al.
Publicado: (2023)

The immune cell landscape of peripheral blood mononuclear cells from PNS patients
por: Ye, Qing, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mamj5155ffb69o7v7o4nnn8vdv